Kailera Therapeutics, Inc. (KLRA)
11.04
-0.29
(-2.56%)
USD |
NASDAQ |
Oct 13, 12:37
Kailera Therapeutics Price to Book Value : 1.279 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.313 |
| October 09, 2026 | 1.346 |
| October 08, 2026 | 1.159 |
| October 07, 2026 | 1.220 |
| October 06, 2026 | 1.255 |
| October 05, 2026 | 1.256 |
| October 02, 2026 | 1.204 |
| October 01, 2026 | 1.278 |
| September 30, 2026 | 1.324 |
| September 29, 2026 | 1.274 |
| September 28, 2026 | 1.289 |
| September 25, 2026 | 1.300 |
| September 24, 2026 | 1.388 |
| September 23, 2026 | 1.522 |
| September 22, 2026 | 1.482 |
| September 21, 2026 | 1.390 |
| September 18, 2026 | 1.487 |
| September 17, 2026 | 1.497 |
| September 16, 2026 | 1.472 |
| September 15, 2026 | 1.559 |
| September 14, 2026 | 1.594 |
| September 11, 2026 | 1.616 |
| September 10, 2026 | 1.728 |
| September 09, 2026 | 1.720 |
| September 08, 2026 | 1.904 |
| Date | Value |
|---|---|
| September 04, 2026 | 1.881 |
| September 03, 2026 | 1.824 |
| September 02, 2026 | 1.837 |
| September 01, 2026 | 1.902 |
| August 31, 2026 | 1.785 |
| August 28, 2026 | 1.879 |
| August 27, 2026 | 2.148 |
| August 26, 2026 | 2.137 |
| August 25, 2026 | 2.057 |
| August 24, 2026 | 1.917 |
| August 21, 2026 | 1.990 |
| August 20, 2026 | 2.024 |
| August 19, 2026 | 2.123 |
| August 18, 2026 | 2.066 |
| August 17, 2026 | 2.145 |
| August 14, 2026 | 2.079 |
| August 13, 2026 | 2.083 |
| August 12, 2026 | 2.154 |
| August 11, 2026 | 2.187 |
| August 10, 2026 | 2.200 |
| August 07, 2026 | 2.162 |
| August 06, 2026 | 2.187 |
| August 05, 2026 | 2.106 |
| August 04, 2026 | 2.099 |
| August 03, 2026 | 2.007 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 21.56 |
| Prime Medicine, Inc. | 14.98 |
| GRAIL, Inc. | 2.489 |
| Arrowhead Pharmaceuticals, Inc. | 17.84 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| Price | 11.04 |
| Earnings Yield | -15.31% |
| Market Cap | 1.431B |